Beyond market trends, investors looking for superior returns explore the world of stock picking. The right selections can be a powerful driver for wealth accumulation.
In the latest session, Actinium Pharmaceuticals Inc (AMEX: ATNM) closed at $1.36 down -3.55% from its previous closing price of $1.41. In other words, the price has decreased by -$3.55 from its previous closing price. On the day, 0.25 million shares were traded. ATNM stock price reached its highest trading level at $1.4263 during the session, while it also had its lowest trading level at $1.35.
Ratios:
For a deeper understanding of Actinium Pharmaceuticals Inc’s stock, let’s take a closer look at its various ratios. For the most recent quarter (mrq), Quick Ratio is recorded 7.96 and its Current Ratio is at 7.96. In the meantime, Its Debt-to-Equity ratio is 0.08 whereas as Long-Term Debt/Eq ratio is at 0.04.
Upgrades & Downgrades
. In the most recent recommendation for the company, B. Riley Securities on August 07, 2024, Downgraded its rating to Neutral and sets its target price to $2 from $16 previously.
On May 14, 2024, Stephens started tracking the stock assigning a Overweight rating and target price of $25.
On September 06, 2023, HSBC Securities started tracking the stock assigning a Buy rating and target price of $11.60.HSBC Securities initiated its Buy rating on September 06, 2023, with a $11.60 target price.
Valuation Measures:
Investors should consider key stock statistics when deciding whether to invest or divest. In the wake of the recent closing price, ATNM now has a Market Capitalization of 42426412 and an Enterprise Value of -9821588. For the stock, the TTM Price-to-Sale (P/S) ratio is 471.45 while its Price-to-Book (P/B) ratio in mrq is 3.08. Its current Enterprise Value per Revenue stands at -109.129 whereas that against EBITDA is 0.265.
Stock Price History:
The Beta on a monthly basis for ATNM is -0.30, which has changed by 0.11904764 over the last 52 weeks, in comparison to a change of 0.17511821 over the same period for the S&P500. Over the past 52 weeks, ATNM has reached a high of $2.41, while it has fallen to a 52-week low of $1.03. The 50-Day Moving Average of the stock is -5.24%, while the 200-Day Moving Average is calculated to be -11.13%.
Shares Statistics:
For the past three months, ATNM has traded an average of 226.84K shares per day and 170750 over the past ten days. A total of 31.20M shares are outstanding, with a floating share count of 30.22M. Insiders hold about 3.12% of the company’s shares, while institutions hold 19.02% stake in the company. Shares short for ATNM as of 1765756800 were 890605 with a Short Ratio of 3.93, compared to 1763078400 on 853887. Therefore, it implies a Short% of Shares Outstanding of 890605 and a Short% of Float of 2.87.
Earnings Estimates
Investors are eagerly awaiting the insights provided by 3.0 analysts currently analyzing and rating the stock of Actinium Pharmaceuticals Inc (ATNM).The consensus estimate for the next quarter is -$0.2, with high estimates of -$0.2 and low estimates of -$0.2. Analysts are recommending an EPS of between -$1.07 and -$1.09 for the fiscal current year, implying an average EPS of -$1.08. EPS for the following year is -$0.74, with 3.0 analysts recommending between -$0.61 and -$0.84.
